HESTER BIOSCIENCES
Back to Cashflow Statement
|
HESTER BIOSCIENCES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹64 Cr | ₹65 Cr | ₹48 Cr | ₹24 Cr | ₹8.71 Cr |
What is the latest Cash Flow from Operating Activities ratio of HESTER BIOSCIENCES ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹64 Cr |
| Mar2025 | ₹65 Cr |
| Mar2024 | ₹48 Cr |
| Mar2023 | ₹24 Cr |
| Mar2022 | ₹8.71 Cr |
How is Cash Flow from Operating Activities of HESTER BIOSCIENCES Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹64 Cr | -0.57 | |
| Mar2025 | ₹65 Cr | 33.89 | |
| Mar2024 | ₹48 Cr | 104.20 | |
| Mar2023 | ₹24 Cr | 170.84 | |
| Mar2022 | ₹8.71 Cr | - | |
Compare Cash Flow from Operating Activities of peers of HESTER BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HESTER BIOSCIENCES | ₹1,877.5 Cr | -0% | 13% | 19.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
HESTER BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HESTER BIOSCIENCES | -0% |
13% |
19.9% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses